 | • レポートコード：QY20ST-05249 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のパンデミックインフルエンザワクチン市場について種類別（A型インフルエンザ（H1N1）ワクチン、その他）、用途別（成人、小児科）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・パンデミックインフルエンザワクチン市場の概要 ・世界の主要地域別パンデミックインフルエンザワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のパンデミックインフルエンザワクチン市場規模2015-2026：種類別（A型インフルエンザ（H1N1）ワクチン、その他） ・世界のパンデミックインフルエンザワクチン市場規模2015-2026：用途別（成人、小児科） ・パンデミックインフルエンザワクチンの北米市場規模2015-2020 ・パンデミックインフルエンザワクチンのヨーロッパ市場規模2015-2020 ・パンデミックインフルエンザワクチンの中国市場規模2015-2020 ・パンデミックインフルエンザワクチンの日本市場規模2015-2020 ・パンデミックインフルエンザワクチンの東南アジア市場規模2015-2020 ・パンデミックインフルエンザワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・パンデミックインフルエンザワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・パンデミックインフルエンザワクチンの市場動向・機会・課題 ・調査の結論 |
Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.
Market Analysis and Insights: Global Pandemic Influenza Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pandemic Influenza Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pandemic Influenza Vaccine industry.
Based on our recent survey, we have several different scenarios about the Pandemic Influenza Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Pandemic Influenza Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Pandemic Influenza Vaccine Scope and Market Size
The global Pandemic Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pandemic Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pandemic Influenza Vaccine market is segmented into
Influenza A (H1N1) Vaccines
Other
Segment by Application, the Pandemic Influenza Vaccine market is segmented into
Adult
Paediatric
The Pandemic Influenza Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pandemic Influenza Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pandemic Influenza Vaccine Market Share Analysis
Pandemic Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pandemic Influenza Vaccine business, the date to enter into the Pandemic Influenza Vaccine market, Pandemic Influenza Vaccine product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
Valneva
Lupin
Chiron Panacea
Solvay and Serum Institute of India Pvt. Ltd.
Sementis
1 Pandemic Influenza Vaccine Market Overview
1.1 Pandemic Influenza Vaccine Product Scope
1.2 Pandemic Influenza Vaccine Segment by Type
1.2.1 Global Pandemic Influenza Vaccine Sales by Type (2020-2026)
1.2.2 Influenza A (H1N1) Vaccines
1.2.3 Other
1.3 Pandemic Influenza Vaccine Segment by Application
1.3.1 Global Pandemic Influenza Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Adult
1.3.3 Paediatric
1.4 Pandemic Influenza Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pandemic Influenza Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Pandemic Influenza Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Pandemic Influenza Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Pandemic Influenza Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Pandemic Influenza Vaccine Industry
1.5.1.1 Pandemic Influenza Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Pandemic Influenza Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Pandemic Influenza Vaccine Players to Combat Covid-19 Impact
2 Pandemic Influenza Vaccine Estimate and Forecast by Region
2.1 Global Pandemic Influenza Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pandemic Influenza Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Pandemic Influenza Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pandemic Influenza Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pandemic Influenza Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pandemic Influenza Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Pandemic Influenza Vaccine Estimates and Projections (2015-2026)
2.4.3 China Pandemic Influenza Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Pandemic Influenza Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pandemic Influenza Vaccine Estimates and Projections (2015-2026)
2.4.6 India Pandemic Influenza Vaccine Estimates and Projections (2015-2026)
3 Global Pandemic Influenza Vaccine Competition Landscape by Players
3.1 Global Top Pandemic Influenza Vaccine Players by Sales (2015-2020)
3.2 Global Top Pandemic Influenza Vaccine Players by Revenue (2015-2020)
3.3 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pandemic Influenza Vaccine as of 2019)
3.4 Global Pandemic Influenza Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Pandemic Influenza Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pandemic Influenza Vaccine Players (Opinion Leaders)
4 Global Pandemic Influenza Vaccine Market Size by Type
4.1 Global Pandemic Influenza Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Pandemic Influenza Vaccine Price by Type (2014-2020)
4.2 Global Pandemic Influenza Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Pandemic Influenza Vaccine Price Forecast by Type (2021-2026)
5 Global Pandemic Influenza Vaccine Market Size by Application
5.1 Global Pandemic Influenza Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Pandemic Influenza Vaccine Price by Application (2015-2020)
5.2 Global Pandemic Influenza Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pandemic Influenza Vaccine Price Forecast by Application (2021-2026)
3 North America Pandemic Influenza Vaccine Market Facts & Figures
3.2 North America Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
4 Europe Pandemic Influenza Vaccine Market Facts & Figures
4.2 Europe Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
5 China Pandemic Influenza Vaccine Market Facts & Figures
5.2 China Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
5.3 China Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
5.4 China Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
6 Japan Pandemic Influenza Vaccine Market Facts & Figures
6.2 Japan Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Pandemic Influenza Vaccine Market Facts & Figures
7.2 Southeast Asia Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
8 India Pandemic Influenza Vaccine Market Facts & Figures
8.2 India Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
8.3 India Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
8.4 India Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pandemic Influenza Vaccine Business
12.1 AstraZeneca
12.1.1 AstraZeneca Pandemic Influenza Vaccine Corporation Information
12.1.2 AstraZeneca Pandemic Influenza Vaccine Business Overview and Total Revenue
12.1.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
12.1.5 AstraZeneca Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Pandemic Influenza Vaccine Corporation Information
12.2.2 GlaxoSmithKline Pandemic Influenza Vaccine Business Overview and Total Revenue
12.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Pandemic Influenza Vaccine Corporation Information
12.3.2 Novartis Pandemic Influenza Vaccine Business Overview and Total Revenue
12.3.3 Novartis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Pandemic Influenza Vaccine Products Offered
12.3.5 Novartis Recent Development
12.4 Sanofi
12.4.1 Sanofi Pandemic Influenza Vaccine Corporation Information
12.4.2 Sanofi Pandemic Influenza Vaccine Business Overview and Total Revenue
12.4.3 Sanofi Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Pandemic Influenza Vaccine Products Offered
12.4.5 Sanofi Recent Development
12.5 Valneva
12.5.1 Valneva Pandemic Influenza Vaccine Corporation Information
12.5.2 Valneva Pandemic Influenza Vaccine Business Overview and Total Revenue
12.5.3 Valneva Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Valneva Pandemic Influenza Vaccine Products Offered
12.5.5 Valneva Recent Development
12.6 Lupin
12.6.1 Lupin Pandemic Influenza Vaccine Corporation Information
12.6.2 Lupin Pandemic Influenza Vaccine Business Overview and Total Revenue
12.6.3 Lupin Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lupin Pandemic Influenza Vaccine Products Offered
12.6.5 Lupin Recent Development
12.7 Chiron Panacea
12.7.1 Chiron Panacea Pandemic Influenza Vaccine Corporation Information
12.7.2 Chiron Panacea Pandemic Influenza Vaccine Business Overview and Total Revenue
12.7.3 Chiron Panacea Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered
12.7.5 Chiron Panacea Recent Development
12.8 Solvay and Serum Institute of India Pvt. Ltd.
12.8.1 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Corporation Information
12.8.2 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Business Overview and Total Revenue
12.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered
12.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development
12.9 Sementis
12.9.1 Sementis Pandemic Influenza Vaccine Corporation Information
12.9.2 Sementis Pandemic Influenza Vaccine Business Overview and Total Revenue
12.9.3 Sementis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sementis Pandemic Influenza Vaccine Products Offered
12.9.5 Sementis Recent Development
13 Pandemic Influenza Vaccine Manufacturing Cost Analysis
13.1 Pandemic Influenza Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pandemic Influenza Vaccine
13.4 Pandemic Influenza Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pandemic Influenza Vaccine Distributors List
14.3 Pandemic Influenza Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pandemic Influenza Vaccine Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Pandemic Influenza Vaccine Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Pandemic Influenza Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Pandemic Influenza Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Pandemic Influenza Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Pandemic Influenza Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Pandemic Influenza Vaccine Sales (K Doses) by Region (2015-2020)
Table 10. Global Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Pandemic Influenza Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Pandemic Influenza Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Pandemic Influenza Vaccine Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Pandemic Influenza Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Pandemic Influenza Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Pandemic Influenza Vaccine (K Doses) of Key Companies (2015-2020)
Table 18. Global Pandemic Influenza Vaccine Sales Share by Company (2015-2020)
Table 19. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Pandemic Influenza Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pandemic Influenza Vaccine as of 2019)
Table 22. Global Pandemic Influenza Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Pandemic Influenza Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Pandemic Influenza Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Pandemic Influenza Vaccine Players
Table 27. Global Pandemic Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 28. Global Pandemic Influenza Vaccine Sales Share by Type (2015-2020)
Table 29. Global Pandemic Influenza Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Pandemic Influenza Vaccine Price (K Doses) by Type (2015-2020)
Table 31. Global Pandemic Influenza Vaccine Sales Share by Type (2021-2026)
Table 32. Global Pandemic Influenza Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Pandemic Influenza Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Pandemic Influenza Vaccine Price (K Doses) by Type (2021-2026)
Table 35. Global Pandemic Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 36. Global Pandemic Influenza Vaccine Sales Share by Application (2015-2020)
Table 37. Global Pandemic Influenza Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Pandemic Influenza Vaccine Price (K Doses) by Application (2015-2020)
Table 39. Global Pandemic Influenza Vaccine Sales (K Doses) by Application (2021-2026)
Table 40. Global Pandemic Influenza Vaccine Sales Share by Application (2021-2026)
Table 41. Global Pandemic Influenza Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Pandemic Influenza Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Pandemic Influenza Vaccine Price (K Doses) by Application (2021-2026)
Table 44. United States Pandemic Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 45. United States Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Pandemic Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 47. United States Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Pandemic Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 49. United States Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Pandemic Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 51. Europe Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Pandemic Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 53. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Pandemic Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 55. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Pandemic Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 57. China Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Pandemic Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 59. China Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Pandemic Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 61. China Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Pandemic Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 63. Japan Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Pandemic Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 65. Japan Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Pandemic Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 67. Japan Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Pandemic Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Pandemic Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Pandemic Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Pandemic Influenza Vaccine Sales (K Doses) by Company (2015-2020)
Table 75. India Pandemic Influenza Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Pandemic Influenza Vaccine Sales (K Doses) by Type (2015-2020)
Table 77. India Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Pandemic Influenza Vaccine Sales (K Doses) by Application (2015-2020)
Table 79. India Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. AstraZeneca Pandemic Influenza Vaccine Product
Table 84. AstraZeneca Recent Development
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Pandemic Influenza Vaccine Product
Table 89. GlaxoSmithKline Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Novartis Pandemic Influenza Vaccine Product
Table 94. Novartis Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Sanofi Pandemic Influenza Vaccine Product
Table 99. Sanofi Recent Development
Table 100. Valneva Corporation Information
Table 101. Valneva Description and Business Overview
Table 102. Valneva Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Valneva Pandemic Influenza Vaccine Product
Table 104. Valneva Recent Development
Table 105. Lupin Corporation Information
Table 106. Lupin Description and Business Overview
Table 107. Lupin Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Lupin Pandemic Influenza Vaccine Product
Table 109. Lupin Recent Development
Table 110. Chiron Panacea Corporation Information
Table 111. Chiron Panacea Description and Business Overview
Table 112. Chiron Panacea Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Chiron Panacea Pandemic Influenza Vaccine Product
Table 114. Chiron Panacea Recent Development
Table 115. Solvay and Serum Institute of India Pvt. Ltd. Corporation Information
Table 116. Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Solvay and Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 118. Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Product
Table 119. Solvay and Serum Institute of India Pvt. Ltd. Recent Development
Table . Sementis Corporation Information
Table . Sementis Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Sementis Description and Business Overview
Table . Sementis Pandemic Influenza Vaccine Product
Table . Sementis Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Pandemic Influenza Vaccine Distributors List
Table 128. Pandemic Influenza Vaccine Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Pandemic Influenza Vaccine Product Picture
Figure 2. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pandemic Influenza Vaccine Market Share by Application in 2020 & 2026
Figure 6. Adult Examples
Figure 7. Paediatric Examples
Figure 8. Global Pandemic Influenza Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Pandemic Influenza Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Pandemic Influenza Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Pandemic Influenza Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Pandemic Influenza Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Pandemic Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Pandemic Influenza Vaccine Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Pandemic Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Pandemic Influenza Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Pandemic Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Pandemic Influenza Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Pandemic Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Pandemic Influenza Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Pandemic Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pandemic Influenza Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Pandemic Influenza Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Pandemic Influenza Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Pandemic Influenza Vaccine Players Market Share by Revenue in Pandemic Influenza Vaccine 2015 & 2019
Figure 26. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Pandemic Influenza Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Pandemic Influenza Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Pandemic Influenza Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Pandemic Influenza Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 32. United States Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Pandemic Influenza Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Pandemic Influenza Vaccine Sales Market Share by Application in 2019
Figure 36. China Pandemic Influenza Vaccine Sales Market Share by Company in 2019
Figure 37. China Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 38. China Pandemic Influenza Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Pandemic Influenza Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Pandemic Influenza Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Pandemic Influenza Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Pandemic Influenza Vaccine Sales Market Share by Application in 2019
Figure 45. India Pandemic Influenza Vaccine Sales Market Share by Company in 2019
Figure 46. India Pandemic Influenza Vaccine Sales Market Share by Type in 2019
Figure 47. India Pandemic Influenza Vaccine Sales Market Share by Application in 2019
Figure 48. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Valneva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Chiron Panacea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Solvay and Serum Institute of India Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Sementis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Pandemic Influenza Vaccine
Figure 59. Manufacturing Process Analysis of Pandemic Influenza Vaccine
Figure 60. Pandemic Influenza Vaccine Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
季節性インフルエンザワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Seasonal Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD 4404.4 million by 2025, from USD 4067.8 million in 2019. The Seasonal …- 抗インフルエンザ薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-influenza Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 従来式インフルエンザ診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Traditional influenza diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Traditional …
- 分子インフルエンザ診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Influenza Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Molecular Infl…
- 帯状疱疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Shingles Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Shingles Vaccine market repo…